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Abstract
A key event during mammalian sexual development is regression of the Müllerian ducts (MDs) in
the bipotential urogenital ridges (UGRs) of fetal males, which is caused by the expression of
Müllerian inhibiting substance (MIS) in the Sertoli cells of the differentiating testes. The paracrine
signaling mechanisms involved in MD regression are not completely understood, particularly
since the receptor for MIS, MISR2, is expressed in the mesenchyme surrounding the MD, but
regression occurs in both the epithelium and mesenchyme. Microarray analysis comparing MIS
signaling competent and Misr2 knockout embryonic UGRs was performed to identify secreted
factors that might be important for MIS-mediated regression of the MD. A seven-fold increase in
the expression of Wif1, an inhibitor of WNT/β-catenin signaling, was observed in the Misr2-
expressing UGRs. Whole mount in situ hybridization of Wif1 revealed a spatial and temporal
pattern of expression consistent with Misr2 during the window of MD regression in the
mesenchyme surrounding the MD epithelium that was absent in both female UGRs and UGRs
knocked out for Misr2. Knockdown of Wif1 expression in male UGRs by Wif1-specific siRNAs
beginning on embryonic day 13.5 resulted in MD retention in an organ culture assay, and exposure
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of female UGRs to added recombinant human MIS induced Wif1 expression in the MD
mesenchyme. Knockdown of Wif1 led to increased expression of β-catenin and its downstream
targets TCF1/LEF1 in the MD mesenchyme and to decreased apoptosis, resulting in partial to
complete retention of the MD. These results strongly suggest that WIF1 secretion by the MD
mesenchyme plays a role in MD regression in fetal males.
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INTRODUCTION
Sexual differentiation of the bipotential embryonic urogenital ridge (UGR) into the testes
and internal male reproductive tract is regulated by the Sex Determining Region Y (SRY)
transcription factor expressed in XY gonads, which leads to the production of three
hormones. The fetal testes produce and secrete both Müllerian inhibiting substance (MIS;
also known as anti-Müllerian hormone, AMH), which causes Müllerian ducts (MDs) to
regress, and testosterone, which promotes the differentiation of the Wolffian ducts into the
internal male reproductive tract tissues, i.e., the epididymides, vasa deferentia, and seminal
vesicles. In the absence of MIS, as is the case with females, MDs do not regress but continue
to develop and differentiate into the oviducts, uterus, and upper vagina (reviewed in
(Teixeira 2001)). Defects in either the gene for MIS or its receptors can result in a form of
male pseudohermaphroditism characterized by retained MD-derived tissues (Behringer
1994; Mishina 1996; Jamin 2002). In humans, approximately 85% of patients with persistent
Müllerian duct syndrome (PMDS) are thought to have underlying mutations in MIS or its
receptors (Belville 2004; Josso 2005). The third hormone, insulin-like 3 (INSL3), is
produced by the pre-and postnatal testes and is necessary for testicular descent (Nef and
Parada 1999; Zimmermann 1999).
As with other members of the transforming growth factor β (TGFβ) super family, MIS binds
to its specific type II receptor (MISR2), which activates its latent kinase, causing recruitment
and phosphorylation of a type I receptor, either ACVR1 (ALK2) or BMPR1A (ALK3), to
initiate a downstream signaling cascade that results in apoptosis and regression of the MDs
(Teixeira 2001; Josso and Clemente 2003). The MDs first form from coelomic epithelial
cells that invaginate, proliferate, and migrate in a cranial-to-caudal direction to merge with
the urogenital sinus epithelium (Guioli 2007; Orvis and Behringer 2007; Fujino 2009). The
MDs are similarly eliminated in a cranial-to-caudal manner as a result of MIS action (Picon
1969; Tsuji 1992), which is attributable to the cranial-to-caudal expression of Misr2 (Allard
2000; Arango 2008). We have recently shown that Misr2-expressing cells are initially
present in the coelomic epithelium and subjacent mesenchyme of both male and female
UGRs, but that under the influence of MIS, the Misr2-expressing cells proliferate and
migrate into the mesenchyme surrounding the male MD (Hayashi 1982; Trelstad 1982; Zhan
2006). We and others have also shown that expression of the MIS type I receptors, is also
spatiotemporally controlled, and that the SMAD1, 5 and 8 subfamily of intracellular signal
transducers are involved in MD regression (Gouedard 2000; Clarke 2001; Visser 2001; Zhan
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2006; Orvis 2008). One of the important unanswered questions in MD regression is how
MISR2, which is expressed in the mesenchyme surrounding the MD but not in the MD
epithelial cells at the time of regression (Baarends 1994; di Clemente 1994; Teixeira 1996),
induces apoptosis in the neighboring epithelial cells (Tsuji 1992; Teixeira 1996; Catlin
1997; Allard 2000).
WNT/β-catenin signaling is known to be crucial for normal uterine development from the
MDs in females (Kobayashi and Behringer 2003). For example, Wnt5a knockout mice
display anomalous development of the uterine horns, cervix and vagina, and the uteri from
Wnt7a knockout mice have defective myometria, endometrial glands, and oviductal
structures (Miller and Sassoon 1998; Parr and McMahon 1998; Mericskay 2004). The MD
mesenchyme-specific expression of Wnt5A and MD epithelium-specific expression of
Wnt7A adds further complexity to the respective roles in uterine development (Mericskay
2004). The different phenotypes observed by the knockout of either Wnt7a or Wnt5a
suggests that these ligands have different functional roles, which might be attributable to the
separate signaling pathways used by the respective ligands, i.e., the canonical β-catenin
pathway for WNT7A (Mikels and Nusse 2006b) and the Ca2+ or planar cell polarity
pathway for WNT5A (Loscertales 2008; Romereim and Dudley 2011). However, WNT5A
can signal through the canonical β-catenin pathway, depending on specific WNT receptor
expression (He 1997; Mikels and Nusse 2006a; van Amerongen 2012).
WNT signaling is not only important for uterine development in females, it is also a key
factor in MD regression in male fetuses. Male Wnt7a knockout mice have retained MDs
(Miller and Sassoon 1998; Parr and McMahon 1998), so far the only Wnt family gene
knockout reported to develop this phenotype. However, Misr2 mRNA expression is also lost
in Wnt7a knockout mice, thereby abrogating MIS signaling and precluding any inference on
its role in the downstream activity of β-catenin. Nuclear accumulation of β-catenin has been
reported in the MD mesenchyme cells during MD regression (Allard 2000), and male mice
with conditional knockout of β-catenin from the MD mesenchyme were shown to have
retained MDs (Kobayashi 2011), indicating that nuclear β-catenin activity in the MD
mesenchyme is necessary for MD regression. Taken together, these studies support a dual
role for WNT/β-catenin signaling in MD biology, one for regression in males and another
for differentiation in females. We have shown that either conditional knockout of β-catenin
or constitutive activation of β-catenin in the MD mesenchyme leads to myometrial
pathologies in female mice (Arango 2005; Tanwar 2009) and that constitutive activation of
β-catenin in the MD mesenchyme predisposes male mice to focal MD retention (Tanwar
2010). Thus, it appears that the contradictory finding that MD retention in males with either
β- catenin knockout (Kobayashi 2011) or constitutive activation of β-catenin (Tanwar 2010)
using the same Misr2-driven Cre would suggest that MD regression is exquisitely sensitive
to WNT/β-catenin signaling in the MD mesenchyme or that highly localized
microenvironmental factors that modulate WNT/β- catenin signaling might need to act in
concert with β-catenin to complete MD regression in males. In contrast to the critical roles
played by WNT/β-catenin signaling in the MD mesenchyme, its expression in the MD
epithelium does not appear to be necessary for MD regression (Kobayashi 2011).
Park et al. Page 3
Dev Biol. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
We have identified WNT inhibitory factor 1 (WIF1) (Hsieh 1999) as a candidate
intercellular factor involved in the MIS/MISR2-mediated regulation of MD regression using
microarray analyses of Misr2 homozygous knockout UGRs compared with heterozygous
controls. Here we show that MIS induces expression of Wif1 mRNA during normal MD
regression in males and that knockdown of Wif1 by siRNA leads to partial retention of the
MD epithelium in UGR assays. These results suggest that the dual roles played by β-catenin
in MD retention and regression can be controlled by the local expression of WNT inhibitors
such as WIF1.
METHODS
Microarray analysis of Misr2 knockout and control mice
Mice used in this study were housed under standard animal housing conditions and
maintained on a C57BL/6;129/SvEv mixed genetic background. The Institutional Animal
Care and Use Committee at Massachusetts General Hospital approved the protocols for
animal experimentations performed in this study. YFP mice (Gt(ROSA)26Sortm1(EYFP)Cos,
obtained from Dr. Frank Costantini (Srinivas 2001)) were mated with Misr2-LacZ mice
(Amhr2tm2(LacZ)Bhr, obtained from Dr. Richard Behringer (Arango 2008)) to obtain
homozygous YFP/YFP;Misr2-LacZ/Misr2-LacZ females, which were then mated with male
Misr2-Cre/+ (Amhr2tm3(cre)Bhr, obtained from Dr. Richard Behringer (Jamin 2002)) mice to
produce Misr2-Cre/Misr2-LacZ;YFP/+ embryos that are knocked out for Misr2 and cannot
transduce MIS signaling but express the YFP reporter or Misr2-LacZ/+;YFP/+ embryos that
can transduce MIS signaling and do not express the YFP reporter. Genotyping was
performed when necessary with DNA collected from tail biopsies using standard PCR
protocols. Timed pregnant matings were performed and the presence of a vaginal plug in the
morning was considered embryonic day 0.5 (E0.5) at 12 p.m. UGRs of the male embryos
were sorted manually by YFP fluorescence (YFP+ were Misr2 knockouts, YFP− were Misr2
heterozygotes) using a fluorescence dissecting microscope, and the mesonephroi were
dissected away from the gonads with a scalpel as cleanly as possible, pooled, frozen and
stored at −80 C. Female UGRs were discarded. Total RNA was prepared (~5 ug) from
approximately 200 mesonephroi for each genotype, the mRNA converted to cRNA, and
compared by microarray analyses using the Affymetrix oligonucleotide chips (Mouse430_2)
at the Harvard/Partners Center for Personalized Genetic Medicine. Data from the microarray
analysis has been deposited in the GEO database under the accession number GSE38009.
Animals, organ culture and recombinant human MIS
UGRs were dissected from wildtype embryos of timed pregnant mice and studied at
developmental stages E12.5, E13.5 and E14.5, to determine normal gene expression patterns
and morphological changes in vivo. UGRs collected from timed pregnant mice at E13.5
were also dissected and then cultured on MilliCell-CM membrane (Millipore, Bellerica,
MA) over 2% agarose gel droplets immersed in CMRL 1066 medium (Life Technologies,
Grand Island, NY) supplemented with 10% female fetal bovine serum (Aires Scientific/Bio-
logos, Richardson, Texas) to avoid bovine MIS in male serum, 100 U/ml penicillin, 100
ug/ml streptomycin, and 10 nM testosterone, which stimulates Wolffian duct development,
for comparison with MDs. Cultures were carried out with or without recombinant human
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MIS (rhMIS) at a final concentration of 6 ug/ml (42.5 nM). MIS was purified from serum-
containing media of Chinese hamster ovary clonal cells expressing native MIS by
immunoaffinity chromatography as described previously (Ragin 1992).
RNA probes
Digoxigenin-labeled antisense and sense riboprobes were generated by in vitro transcription
using digoxigenin-labeled nucleotide mix (Roche, Indianapolis, IN) according to the
manufacturer’s instructions. A PCR fragment of Wnt7a coding sequence (NM_009527;
nucleotides 335–970) was subcloned into pCRII-TOPO (Life Technologies), digested with
EcoRV, and transcribed with Sp6 RNA polymerase to make antisense probes. A PCR
fragment of coding sequence of Wif1 (NM_011915; nucleotides 516–1131) was cloned from
a mouse testis cDNA library into pCR2.1-TOPO (Life Technologies), digested with SpeI,
and transcribed with T7 RNA polymerase to make antisense probes. The Mis plasmid
(Swain 1998) was digested with SmaI and transcribed with T7 RNA polymerase for the
antisense probe. The probe for Misr2 was made as previously described (Clarke 2001). All
templates were purified using phenol-chloroform-isoamyl alcohol and ether for RNase-free
conditions.
In situ hybridization
Immediately following dissection at various gestational ages or after organ culture in
RNase-free conditions, UGRs were fixed for 2 h at 4 C in 4% paraformaldehyde (PFA). The
UGRs were dehydrated and stored in 100% methanol until further use. Tissues were
rehydrated, treated with hydrogen peroxide, then with 10 g/ml proteinase K, pre-hybridized,
and hybridized with digoxigenin-labeled sense or antisense riboprobes overnight at 70 C. A
minimum of 3 UGRs was used for each experimental condition. After high-stringency
washing, the samples were placed in 10% Sheep serum/TBS-T for 1.5 h at room temperature
for blocking, then incubated with anti-digoxigenin-AP antibody (Roche) at 1:2000 overnight
at 4 C with gentle rocking. The signals were visualized using the BM-Purple alkaline
phosphatase substrate (Roche). For frozen sections, samples were embedded in O.C.T.
compound and subsequently cryosectioned at 16 um. Photos were taken with an Nikon
SMZ1500 dissecting microscope with a Spot digital camera (Diagnostic Instruments,
Sterling Heights, MI)
RNAi in organ culture
A cocktail of siRNA duplex oligoribonucleotides of Wif1 (MSS280614, MSS280615,
MSS280616) and negative control duplexes were purchased from Life Technologies. RNAi
in organ culture was performed as described previously (Zhan 2006). siRNA concentrations
between 50 and 400 nM were tested with murine embryonal fibroblasts using the Alexa
Fluor-555 siRNA control (Life Technologies) for optimal silencing efficiency and minimal
toxicity; as a result, 200 nM was selected for further studies. UGRs from E13.25 were
transfected with siRNA duplex in serum-free culture medium by using the Oligofectamine
RNAiMAX reagent (Life Technologies). siRNAs and Oligofectamine were diluted in
separate tubes in OptiMEM (Life Technologies), combined and incubated for 20 min at
room temperature. The siRNA:Oligofectamine mixture was added to the medium and
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incubated with immersed UGRs for 12 h. The UGRs were subsequently placed on MilliCell-
CM membranes to continue culture for an additional 60 h at the air-media interface over
complete medium. The tissues were then fixed in 4% PFA for either whole mount in situ
hybridization or immunofluorescence staining.
Immunofluorescence staining following Wif1 siRNA treatment of UGRs
For immunofluorescence staining, UGRs were incubated in 15% sucrose solution for 2 h
followed by embedding in 7.5% gelatin/15% sucrose. The embedded tissues were frozen at
−60 C in isopentane and sectioned at 9 um. For β-catenin, TCF1 and LEF1 immunostaining,
serial sections were washed in PBS three times consecutively. Sections were then washed in
PBST and blocked with 10% donkey serum, 1% bovine serum albumin, and 0.1% triton-X
in PBS for β-catenin or 5% goat serum and 0.1% triton-X for TCF1/LEF1 in TBST, 1 h at
room temperature. Tissue sections were then incubated in a humidified chamber overnight at
4 C with anti-β-catenin primary antibody (1:250; BD Transduction Laboratories, San Jose,
CA), anti-TCF1 and anti-LEF1 primary antibodies (1:500; Cell signaling Technologies,
Danvers, MA). Tissue sections were subsequently washed with PBS-T, incubated for 1 h at
room temperature with AlexaFluor secondary antibodies (1:250; Life Technologies), then
counterstained with 4′,6′-diamidino-2-phenylindole (DAPI). Images were photographed
using a microscope (Nikon Eclipse TE 2000-S) equipped with a Spot digital camera.
TUNEL assay
After transfecting E13.5 male UGRs with Wif1 siRNA and RNAi for 12 h, they were
incubated for an additional 48 h in complete medium. The UGRs were fixed in 4% PFA at 4
C for 2 h, washed in PBS and kept at 4 C for immediate assay or stored in 70% ethanol at 4
C for later analysis. The UGRs were post fixed in cold ethanol:acetic acid at a 2:1 ratio for 5
min at −20 C for permeabilization. Terminal deoxynucleotidyl Transferase enzyme and anti-
digoxigenin conjugates were applied according to the ApopTag Plus Fluorescein In Situ kit
(Millipore) manufacturer’s protocol. Counterstaining was performed with DAPI, and the
UGRs were examined with a dissecting microscope. Discrete TUNEL+ cells lining the
Müllerian duct were manually counted in photos of longitudinal planes obtained after
identifying the section where the Müllerian duct was present along with sections
approximately 100 um above and below. As a result, 3 sections per ridge for 5 control ridges
and 6 Wif1 siRNA treated ridges were counted.
Statistical Analysis
Results are expressed as mean values ± standard error of mean (SEM) from a minimum of
three individual experiments. Statistical analyses were perfomed by ANOVA or unpaired t-
test as appropriate with Prism 5 (GraphPad, La Jolla, CA). P-values ≤ 0.05 were considered
statistically significant.
RESULTS
MIS induces Wif1 expression in the MD mesenchyme
The MIS ligand will not be able to bind to MD mesenchyme cells lacking the MISR2
receptor and initiate the signaling cascade required for MD regression. To determine which
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genes are induced by MIS signaling during MD regression, a mating scheme was developed
for efficient sorting of heterozygous Misr2 UGRs from homozygous Misr2 knockout UGRs
of E14.5 fetuses without resorting to PCR genotyping (Fig. 1A). The male gonads were
dissected away from the UGRs so that only the duct-containing mesonephroi were collected
and pooled for total RNA isolation enriched for agonadal mRNAs. The results of microarray
analyses of the RNAs from Misr2-expressing UGRs compared to the Misr2 knockout UGRs
are shown in Tables 1 and 2. The loss of Misr2 expression in the knockout RNA (not
shown) was used to validate the ability of the experiment to differentiate between Misr2
knockout and heterozygous UGRs.
Wif1 mRNA expression was induced more than 7-fold in MIS-responsive agonadal UGRs
(Table I). WIF1 belongs to the secreted Frizzled-related protein class of WNT signaling
inhibitors that binds to WNTs, which in turn inhibits their binding to their receptors (Hsieh
1999). Its expression and activity has been reported in a variety of different developmental
pathways that, when disrupted, can lead to developmental anomalies and cancer (Kawano
and Kypta 2003). Because of the importance of WNT signaling for MD differentiation and
regression, we performed whole-mount in situ hybridization to verify the induction of Wif1
mRNA by MIS. UGRs were collected from E13.5 embryos of the Misr2 knockout and
heterozygous embryos. E13.5 was chosen because MD regression is well underway by
E14.5, when it is more difficult to detect the MDs in males. Expression of Wif1 mRNA was
clearly visible along the entire length of the MD and in the testis cords of both Misr2 wild
type and heterozygous UGRs (Fig. 1C & D). In Misr2 knockout UGRs, only trace
expression of Wif1 was observed (Fig. 1B) when stained for an equivalent amount of time as
Misr2-expressing UGRs but which was still higher than that observed with a negative
control sense probe (Fig. 1E). Analyses of the whole-mount UGRs in frozen sections were
done to determine the spatial relationship of Wif1 mRNA expression with respect to the MD
epithelium. In the Misr2 wild type and heterozygous UGRs, expression was localized to the
mesenchyme surrounding the MD epithelium (Fig. 1G & H) where Misr2 is expressed and
to the MD epithelial cells as well. However, the sections from the Misr2 knockout UGR
showed what little Wif1 mRNA was observed localized to the MD epithelial cells (Fig. 1F).
The expression pattern of Wif1 mRNA over time was studied by whole mount in situ
hybridization in male UGRs from E12.5, E13.5 and E14.5 embryos. At E12.5 Wif1 mRNA
expression is essentially negative (Fig. 2A) and frozen section analysis shows that the light
staining in the duct could be an artifact of substrate pooling in the MD lumen (Fig. 2D).
However at E13.5 male UGRs are strongly positive for Wif1 in the mesenchyme
surrounding the MD epithelium, particularly at the cranial end (Fig. 2B & E). In contrast,
female UGRs at this age do not show Wif1 expression by whole mount in situ hybridization
above background (Fig. 2H & I). As MD regression progresses caudally at E14.5, Wif1
expression was observed at the middle to caudal end of the MD where regression has not yet
occurred (Fig. 2C & G). At the cranial end where MD regression has occurred, Wif1
expression is not observed (Fig. 2C & F). In addition to MIS, the embryonic male gonads
produce testosterone, which is necessary for Wolffian duct development and has been shown
to induce Wif1 expression (Keil 2012), and other secreted factors that could account for
induced Wif1 expression in MD mesenchyme in male UGRs compared with females. To
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ensure that Wif1 expression is induced by MIS alone, without the need for any other factor
produced by the fetal male gonads, E13.5 female UGRs were exposed to recombinant
human MIS (6 μg/ml) for 48 h and then analyzed by whole mount in situ hybridization for
Wif1 mRNA. Partial MD regression was observed in female UGRs (Fig. 2J), which like
male UGRs express the Misr2 in the MD mesenchyme (Baarends 1994; di Clemente 1994;
Teixeira 1996), precluding continued expression of Wif1 as was observed in male UGRs
with MD regression (Fig. 2C). Also as with male UGRs (Fig. 2 G), analysis of frozen
sections where MD regression was not complete showed expression of Wif1 in female UGRs
exposed to MIS (Fig. 2K). These results clearly demonstrate the transitory nature of Wif1
expression in a cranial to caudal manner within a narrow window of time in the MD
mesenchyme during male UGR development that is induced by MIS.
Wif1 knockdown inhibits complete MD regression in vitro
To determine whether MD regression in vitro is dependent on MIS-induced expression of
Wif1, knockdown of Wif1 was performed with a cocktail of Wif1-specific siRNA in UGRs
from E13.25 male embryos in organ culture. When the UGRs were treated with negative
control siRNA, complete or near complete regression of the MDs was observed in the UGRs
by whole mount in situ hybridization for Wnt7a mRNA (Fig. 3A), which is specific to the
MD epithelium (Miller and Sassoon 1998; Parr and McMahon 1998). Occasional MD
epithelium was detected, usually in the caudal end, which regresses last (Picon 1969; Tsuji
1992). The whole mount in situ hybridizations clearly demonstrate regression of the MD as
reflected by the absence or reduced level of staining for Wnt7a (Fig. 3C & D). In contrast,
when the UGRs were exposed to a cocktail of Wif1-specific siRNAs, significant retention of
the MDs was observed (Fig. 3B). In some UGRs, Wnt7a expression was observed along the
whole length of the MD (Fig. 3E), but in others caudal expression was most prominent (Fig.
3F). After arbitrarily dividing the MD into three vertical segments, a quantitative
comparison of the rate of MD retention between the control and Wif1 siRNA-treated UGRs
revealed a statistically significant difference (Fig. 3G) in each segment, confirming that
knockdown of Wif1 expression negatively impacts MD regression.
To rule out the possibility that MD retention might be due to an indirect effect of Wif1
siRNA knockdown on the expression of either Mis or Misr2, the experiment was repeated
and the URGs were examined by whole mount in situ hybridization with probes specific for
Mis and Misr2. Neither Mis (Fig. 3H & J) nor Misr2 (Fig. 3I & K) mRNA expression in the
gonads appeared to be affected in the Wif1 siRNA-treated UGRs compared to controls.
Misr2 expression in the MD mesenchyme, while limited to the caudal regions in the control-
treated UGRs undergoing regression, was also observed in the retained MD regions of the
Wif1 siRNA-treated UGRs. In the face of MD regression in controls, changes in Misr2
expression are more difficult to interpret in the Wif1 knockdown UGRs because its
expression is observed as an artifact of MD retention.
We next examined WNT/β-catenin signaling in control and Wif1 knockdown male UGRs
before MD regression is normally completed. Although membranous β-catenin was
observed in the control UGRs, increased β-catenin signal was observed in both the
mesenchymal cells surrounding the MD and the MD epithelial cells of Wif1 siRNA-treated
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UGRs (Fig. 4A and B). Confirmation of increased nuclear β-catenin activity with Wif1
siRNA was observed by strongly increased expression of LEF1 (Fig. 4C and D) and a more
subtle increase in TCF expression (Fig. 4E and F). However, the induction of both these β-
catenin-regulated genes appeared limited to the MD mesenchyme cells, suggesting that the
increased β-catenin expression resulting from Wif1 knockdown was not affecting nuclear β-
catenin activity in the MD epithelial cells. These results would also suggest that during
normal MD regression, MIS-induced WIF1 suppresses WNT/β-catenin signaling in the MD
mesenchyme by an autocrine mechanism.
Because MIS-induced apoptosis in the Müllerian duct epithelium is a key phenotypical
event in male MD regression, the impact of knocking down Wif1 mRNA on apoptosis was
investigated. TUNEL staining for UGRs after Wif1 siRNA (Fig. 4G and H) versus negative
control siRNA treatment (Fig. 4I and J) revealed a significantly increased distribution of
apoptotic cells along the cranial portion of the ridges in the control siRNA treated UGRs
(mean 211 ± 9 SEM vs. 32 ± 3 SEM; p=0.0009) at 60 h post transfection, confirming that
induced WNT signaling negatively affects MD regression.
DISCUSSION
The development of the male or female sex phenotype from the bipotential embryonic
gonads has fascinated reproductive biologists for nearly a century. Aside from its inherent
allure, it is also important to understand sex differentiation because genitourinary disorders
are the most common in human development and of significant clinical importance to
human health and quality of life. These include congenital uterine anomalies,
cryptorchidism, intersex anomalies, hypospadias, and exstrophies, which are currently
treated by surgical intervention, and in some cases combined with hormonal therapy, with
varying degrees of success. Thus, the basic developmental mechanisms underlying gonadal
and reproductive tract development have to be further investigated in order to understand
more fully the underlying etiologies of these genitourinary anomalies with the goal of
developing better and more rational methods to treat these patients. For example, the basic
mechanisms and the complex coordination of regression, retention and selective
differentiation of the Müllerian and Wolffian ducts are not completely understood. Our
results reported here showing that inhibition of WNT signaling in male UGRs after MIS
binds to its receptor, MISR2, in the MD mesenchyme provide an important contribution to
the study of the key mechanisms governing the regression of MD epithelial cells.
We show that inducing WNT signaling by blocking MIS-mediated induction of Wif1 with
subsequent accumulation of β-catenin can result in partial MD retention and support our
previous findings that male mice with constitutively activated β-catenin in the MD
mesenchyme have a focal MD retention phenotype (Tanwar 2010). Conversely, another
report using the same Misr2-Cre allele indicated that β- catenin in the MD mesenchyme is
required for regression (Kobayashi 2011), supporting a previous study that suggested
accumulation of β-catenin was required for MD regression (Allard 2000). Taken together,
these studies suggest an intricately regulated balance of WNT/β-catenin signaling may be
crucial for normal regression of MD in males and that too much or too little β-catenin
activity might in fact interfere with MD regression (Tanwar 2010). A similar phenomenon
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has been observed during lung development, where altering the dosage of β-catenin activity
in vivo by knockout or constitutively activated expression can have profound effects on
epithelial cell differentiation (Mucenski 2003; Okubo and Hogan 2004; Mucenski 2005).
Another possibility is that inhibition of Wif1 expression might be affecting WNT signaling
pathways that do not involve canonical β-catenin activity.
A key finding from our studies shown in Fig. 4, suggests that decreased Wif1 expression
(i.e., more WNT signaling) appears to increase cellular β-catenin levels in both the MD
epithelial cells and in the surrounding mesenchymal cells but induced nuclear expression of
the proteins encoded by the WNT target genes, Lef1 and Tcf1, was only observed in the
mesenchymal cells. Although Wif1 expression appears to be limited to the MD
mesenchyme, it is a secreted factor that binds to WNT proteins and inhibits their binding to
cell surface receptors, and subsequent intracellular paracrine WNT signaling in both the
mesenchyme and adjacent epithelium. These results support the observation that LEF1
expression is observed in the mesenchyme of β-catenin intact UGRs but not in β-catenin
knockout UGRs (Kobayashi 2011). We speculate that the effects of WIF1 on canonical β-
catenin activity appear to be autocrine. These results do not preclude a paracrine function for
WIF1 in the epithelium but do suggest that if there is one, it probably does not require β-
catenin-mediated transcriptional activation.
In addition to Wif1, our analyses comparing Misr2 heterozygous with Misr2 knockout UGRs
showed that the expression of many other genes was changed by loss of MIS signaling
(GSE38009). We chose Wif1 for further analyses because of our interest in β-catenin
signaling during Müllerian duct differentiation. Msx2 and Dlx5 are two other genes highly
induced by MIS signaling in the UGRs that we expect to study further. The induction of
Msx2, a homeobox gene that encodes the muscle segment homeobox homolog 2 protein, in
the male MDs during regression has been previously shown in chicken embryos (Ha 2008).
Although loss of Msx2 has pleiotropic effects in mice, it does not appear to affect fertility
(Satokata 2000), which would be expected in males with retained MDs (Mishina 1996).
However, its loss does appear to exacerbate the deleterious effect of diethylstilbestrol on
Müllerian duct development (Yin 2006) and conditional postnatal knockout of both Msx1
and Msx2 leads to defective uterine implantation (Daikoku 2011). Dlx5, another homeobox
gene that encodes Distal-less homeobox 5 protein, has been implicated in craniofacial, limb,
and bone development (Kraus and Lufkin 2006), but there are no reports linking Dlx5 to
MD development or regression.
We examined whether evidence of MD retention could be observed in both neonatal and 4
week old male Wif1−/− mice (Kansara 2009) but did not observe any MD-derived tissues in
these mice (data not shown). The Wif1−/− mice have yet to provide an overt phenotype
other than an increased susceptibility to develop osteosarcomas, which is very surprising
given the number of diverse processes that WIF1 has been implicated in modulating,
including lung development (Xu 2011), hematopoiesis (Schaniel 2011), and carcinogenesis
(Ramachandran 2012). A recent report showed that Wif1 expression in the mesenchyme of
the urogenital sinus is regulated by androgens and that it enhances prostatic development
(Keil 2012). However, they also reported no obvious prostate phenotype was observed in the
Wif1−/− mice as well. The disparity between the results from the knockdown organ culture
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experiments shown in Fig. 3 and the absent Wif−/− knockout mouse phenotype is
reminiscent of an earlier report showing that, although knockdown of matrix
metalloproteinase 2 (MMP2) inhibited MD regression in organ culture, the Mmp2−/− male
mice did not have retained MD tissues (Roberts 2002). Those authors speculated that
functional redundancy of the MMP family could be mitigating the loss of MMP2 on UGR
development in vivo, which could also be an issue in the Wif1−/− mice with the several
other WNT inhibitors available to replace some WIF1 function. Resolution of these
discrepancies with the numerous critical activities attributed WIF1 and the lack of a Wif1−/
− phenotype is eagerly awaited.
In summary, we have reported gene expression analyses of murine UGRs during MD
regression with and without MIS signaling in order to understand the mechanisms driving a
fundamental aspect of sexual differentiation. We chose Wif1 for follow up studies and
showed for the first time that MIS induces the expression of the Wif1 gene, which encodes
an inhibitor of WNT signaling. Confirmatory studies showed that knockdown of Wif1
mRNA expression interferes with MD regression. Like the role of β-catenin itself during
MD regression, we hypothesize that an exquisitely tuned amount of Wif1 expression is
required for normal reproductive tract development.
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HIGHLIGHTS
1. Müllerian inhibiting substance causes Müllerian duct regression in urogenital
ridges.
2. Gene expression analyses showed Wif1 induction during Müllerian duct
regression.
3. Whole mount in situ confirmed Müllerian inhibiting substance induces Wif1
expression.
4. Knockdown of Wif1 inhibits apoptosis and Müllerian duct regression.
5. Canonical β-catenin activity was induced in urogenital ridges by Wif1
knockdown.
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Figure 1. Wif1 expression is diminished with loss of MIS signaling in UGRs
(A) Schematic showing the breeding and scoring used to distinguish UGRs from Misr2
knockout mice and heterozygous mice. Misr2 knockout UGRs have both the Misr2-Cre and
Misr2-LacZ alleles. The Cre recombinase from the Misr2-Cre allele drives YFP expression,
which is detected by fluorescence. The Misr2-Cre allele is not in the heterozygotes and YFP
expression is not detected. Whole mount in situ hybridization for Wif1 mRNA in male
UGRs from embryonic day 13.5 Misr2 knockout mice (B) displays downregulation of Wif1
as indicated by BM purple compared to Misr2 heterozygous control (C) and wildtype (D)
UGRs, where there is a clear expression along the MD as well as in the gonads. (E) No Wif1
mRNA expression is detected with a sense RNA probe. Frozen sections of the whole mount
in situ hybridized UGRs reveal noticeably higher levels of Wif1 mRNA detection in the
mesenchyme surrounding the MD epithelium of the heterozygous and the wildtype controls
(G and H, respectively) than in the Misr2 knockout (F) or in the sense control (I).
Arrowheads indicate MDs in whole mounts. MD epithelium is outlined with a dashed line in
panels with sections. T= testis, M= Müllerian duct, W= Wolffian duct. Bar=100μm
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Figure 2. MIS induces Wif1 expression
Time course analysis shows expression of Wif1 mRNA by in situ hybridization in male
UGRs at E12.5 (A), E13.5 (B,) and E14.5 (C). Corresponding frozen sections (D, E) show
strongest Wif1 mRNA expression is detected in the MD mesenchyme at E13.5. At E14.5,
Wif1 mRNA is not detectable in rostral sections where the MDs have regressed (C, F) but
more caudal expression is observed where the MD has not yet regressed (C, G). Wif1 mRNA
expression is low or not detectable in female UGR at E13.5 (H, I). In contrast, Wif1 mRNA
is detected in the surrounding mesenchyme of the MDs (arrowhead) in E13.5 female UGRs
exposed to rhMIS for 60 h in organ culture (J, K). M= Müllerian duct, W= Wolffian duct.
MD epithelium is outlined with a dashed line in panels with sections.
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Figure 3. Wif1 mRNA knockdown inhibits MD regression
E13.5 male UGRs were treated with either control scrambled siRNA duplexes or with a
cocktail of Wif1 siRNA duplexes for 12 h and assayed for MD regression after 60 h by
whole mount in situ for Wnt7a, a MD epithelium-specific mRNA. (A) The absence of
Wnt7a in most of the MD epithelium indicates nearly complete regression of the MDs was
observed in most UGRs with control siRNA. (B) Complete MD regression was not observed
in UGRs transfected with Wif1 siRNA. Higher magnification of representative UGRs boxed
in A and B are shown in C–F. Black arrowheads indicate the Wolffian duct and red
arrowheads indicate Wnt7a-postiive MDs. UGRs from three separate sets of experiments
were scored for MD retention for semi-quantitative comparison with the UGRs divided into
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rostral, middle and caudal segments (G). Open circles (○) are male control siRNA-treated
UGRs, and closed circles (●) are Wif1 siRNA-treated UGRs showing significantly fewer
MD regression in all three segments analyzed. Neither Mis in the testes nor Misr2 mRNAs
in the testes and remaining MD appeared to be affected by transfection with Wif1 siRNA (J,
K) compared to controls (H, I). Arrowhead indicates remaining MD with Misr2 mRNA. T =
testis.
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Figure 4. Downstream activities of β-catenin are induced by Wif1 knockdown
Expression of β-catenin (A, B) and its regulated genes, TCF1 (C, D) and LEF1 (E, F), were
analyzed by immunofluorescence in frozen sections in either control siRNA-treated or Wif1
siRNA-treated E13.5 male UGRs at 60 h post transfection. The degree of apoptosis in the
MD was analyzed by determining the number of TUNEL-positive cells located mostly at the
rostral tip (arrowhead) of the UGRs treated with either control siRNA (G) or with Wif1
siRNA (I). White boxed areas in G and I are shown at higher magnification in H and J. M=
MD, W= Wolffian duct, T= testis. MD epithelium is outlined with a dashed line. Nuclei are
stained with DAPI. Bar=100μm.
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Table 1
Genes upregulated with MIS signaling.
Gene Name Accession Fold
Sp6 NM_031183.2 7.715
Wif1 NM_011915.2 7.36
Msx2 NM_013601.2 6.688
Dlx5 NM_010056.2 4.069
Gata5 NM_008093.2 3.939
Ednrb NM_007904.4 3.633
Ablim3 NM_198649.3 3.503
Ncstn NM_021607.3 3.451
Ddx17 NM_199080.2 3.33
Syt1 NM_009306.3 3.273
H2-T23 NM_010398.1 3.219
Mbp NM_010777.3 3.023
Mael NM_175296.4 2.977
Stk31 NM_029916.2 2.951
Dppa4 NM_028610.2 2.937
Rpl39l NM_026594.2 2.914
Pou5f1 NM_013633.3 2.893
Zmat2 NM_025594.3 2.867
Nfatc1 NM_016791 2.76
Helb NM_080446.2 2.751
Dazl NM_010021.5 2.7
Gfra2 NM_008115.2 2.658
Epha4 NM_007936.3 2.634
Ptprd NM_011211.3 2.576
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Table 2
Genes downregulated with MIS signaling.
Gene Name Accession Fold
Fbxo10 NM_001024142.1 −2.744
Phip NM_001081216.1 −2.764
Cnn3 NM_028044.2 −2.944
Spry4 NM_011898.2 −3.112
Hspa14 NM_015765.2 −3.21
Bcas2 NM_026602.3 −3.405
Kif1c NM_153103.2 −4.155
Tfap2c NM_009335.2 −4.37
Kif5b NM_008448.3 −4.406
Mat2a NM_145569.4 −6.663
Fank1 NM_025850.2 −8.488
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